Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-18

Clinical Trial Update: Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

View source ↗

Summary

This completed clinical trial evaluated whether adding Rocklatan after selective laser trabeculoplasty provides improved efficacy compared with artificial tears…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artificial Tears
  • ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Colorado Ophthalmology Associates PC | Conditions: Glaucoma | Status: COMPLETED